Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Non Operating Income (2020 - 2025)

Neuroone Medical Technologies' Non Operating Income history spans 8 years, with the latest figure at $19058.0 for Q1 2025.

  • For Q1 2025, Non Operating Income fell 38.54% year-over-year to $19058.0; the TTM value through Mar 2025 reached $77062.0, down 47.81%, while the annual FY2024 figure was $125179.0, 30.72% up from the prior year.
  • Non Operating Income reached $19058.0 in Q1 2025 per NMTC's latest filing, up from $9408.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $83387.0 in Q2 2021 to a low of -$26909.0 in Q1 2023.
  • Average Non Operating Income over 4 years is $25725.7, with a median of $26376.0 recorded in 2024.
  • The largest YoY upside for Non Operating Income was 215.23% in 2024 against a maximum downside of 79.36% in 2024.
  • A 4-year view of Non Operating Income shows it stood at $83387.0 in 2021, then tumbled by 45.35% to $45575.0 in 2023, then tumbled by 79.36% to $9408.0 in 2024, then soared by 102.57% to $19058.0 in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Non Operating Income are $19058.0 (Q1 2025), $9408.0 (Q4 2024), and $22220.0 (Q3 2024).